1. Market Research
  2. > Biotechnology

Biotech Industry Outlook: Latest Market Reports & Studies

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
12 votes

Global Biotechnology Industry

The global biotechnology industry is forecast to exceed $320 billion by 2015, reports Global Industry Analysts. Market growth is fuelled by economic recovery, increased R&D funding, government initiatives and biotechnology used in agriculture and medical sciences. Developing nations, particularly China and India, are becoming major markets in the fields of agricultural and industrial biotechnology.

The economic crisis negatively impacted the biotechnology market, and brought about revenue declines in the US and the EU as a result of limited capital inflows and the delay or cancellation of projects. The market has entered a phase of recovery, with many large biotechnology outfits generating revenue thanks to new cost-savings and efficiency measures.

Industry funding is on the rise on the back of more favorable economic conditions, though this funding is concentrated in a small number of larger outfits. Smaller companies are still struggling to raise R&D funds. The situation is likely to improve as venture capitalists exercise greater caution in seeking more secure investment options.

Biotech Key Market Segments

Biological Therapy - The biotechnology industry was further segmented in 2011, steered away from its traditional drug focus and into other fields, including cleantech and chemical manufacturing. BCC Research points to the focus on funding in low-possibility-of-success (POS) areas, such as antineoplastic and immunomodulating agents over other fields with greater success potential such as dermatology or acute diseases.

Genetic Testing represents an important market if we consider diagnosis as the key to better quality healthcare. This segment involves testing for chromosome, protein and gene abnormality or changes linked with inherited medical conditions. The global genetic testing industry is in a period of strong growth, fuelled by rising numbers of genetic disorders, better awareness and an aging population. The market was worth $1.5 billion in 2010, reports RNCOS.

The world genetic testing (and genomics) market is expected to reach $4 billion by 2015. Genetic testing for cancer is likely to experience one of the highest growth rates, receiving particular interest from the private sector and the scientific community at large. Direct-to-consumer genetic testing is a market segment that is likely to take off, with many new outfits on the market. Market shapers include 23andme and deCODE.

Biopharmaceuticals - Global enzyme demand is expected to grow, with the market expected to exceed $7.5 billion in 2010, according to Freedonia. The majority of markets are forecast to record yearly growth in of more than 5%, except for biofuel production and certain other smaller industrial enzyme segments. Regional growth rates will be highest in markets like the Africa/Mideast region, and Central and South America. Growth will be comparatively lower in established economies such as the US and the EU. Enzyme demand in North America will be negatively impacted by a slow switch over to biomass-based biofuel production. EU enzyme demand will be negatively impacted by the EU debt crisis.

Biotech Industry Regional Market Share

The US dominates the global biotechnology industry, followed by developed EU nations such as Germany, Spain, France and the UK, reports Global Industry Analysts. Developing nations like China and India are likely to record strong growth in agricultural and industrial biotechnology industries due to rising income levels and population. Both countries are playing an increasingly significant role in the biotech drugs market on the back of relatively low-cost investment and a high level of expertise.


24/7 Customer Support

Talk to Sam

+44 208 068 8943

1-10 of about 8700 reports

Global Biotechnology Overview

  • September 2017
    35 pages
  • Biotechnology  


    Life Sciences  

  • United States  



View report >

Biotechnology Industry in the US - Forecast

  • July 2017
    6 pages
  • Biotechnology  



  • United States  

View report >

Animal Biotechnology Industry in Europe

  • September 2017
    22 pages
  • Animal Biotechn...  

  • Europe  

    United States  


View report >

Biotechnology Industry in Australia and Japan

  • March 2015
    5 pages
  • Biotechnology  

  • Australia  


View report >

Biotechnology Industry in France

  • October 2016
    30 pages
  • Biotechnology  



  • France  


View report >

Biotechnology Statistics in Germany and Europe

  • May 2017
    68 pages
  • Germany  



View report >

The future of the Biotechnology Industry in the UK

  • January 2016
    48 pages
  • Enzyme  

  • United Kingdom  

View report >

Biotechnology Industry in Canada

  • January 2017
    28 pages
  • Biotechnology  


  • Canada  

    North America  

View report >

The future of the Biotechnology Industry in Brazil

  • August 2015
    15 pages
  • Biotechnology  



  • Brazil  

View report >

Biotechnology Industry in Russian Federation

  • January 2016
    9 pages
  • Biotechnology  

  • Russian Federat...  


View report >

About 2900 reports

Purchase Reports From Reputable Market Research Publishers
(From € 68 - € 16071)

Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

  • € 16071
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global bioreactors market is expected to reach to USD 1,417 million by 2021 from USD 955 million in 2015, at a CAGR of 6.8% between 2015 and 2021.The increase in adoption of single-use technologies, ...

Immuno-oncology Strategic Insight - Multi-indication An ...

May 2016 € 9996

Pharmapoint: Psoriasis - Global Drug Forecast And Marke ...

April 2016 € 9996

Opportunityanalyzer: Growth Hormone Deficiency - Opport ...

May 2017 € 9995

Pharmapoint: Rheumatoid Arthritis - Global Drug Forecas ...

February 2017 € 9995

Pharmapoint: Ulcerative Colitis - Global Drug Forecast ...

January 2017 € 9995

Pharmapoint: Psoriatic Arthritis - Global Drug Forecast ...

December 2016 € 9995

Market Research Of Microalgae Dha In China

April 2017 € 8640

Flat-rate Access To R&d Database & Reports From La Meri ...

November 2016 € 7700

Rheumatoid Arthritis: Payer Insight 2016

November 2016 € 7595

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.